Abstract:The "sphingosin" backbone of sphingolipids was so named by J. L. W. Thudichum in 1884 for its enigmatic ("Sphinx-like") properties. Although still an elusive class of lipids, research on the involvement of sphingolipids in the signal transduction pathways that mediate cell growth, differentiation, multiple cell functions, and cell death has been rapidly expanding our understanding of these compounds. In addition to the newly discovered role of ceramide as an intracellular second messenger for tumor necrosis factor-alpha, IL-1beta, and other cytokines, sphingosine, sphingosine-1-phosphate, and other sphingolipid metabolites have recently been demonstrated to modulate cellular calcium homeostasis and cell proliferation. Perturbation of sphingolipid metabolism using synthetic and naturally occurring inhibitors of key enzymes of the biosynthetic pathways is aiding the characterization of these processes; for examples, inhibition of cerebroside synthase has indicated a role for ceramide in cellular stress responses including heat shock, and inhibition of ceramide synthase (by fumonisins) has revealed the role of disruption of sphingolipid metabolism in several animal diseases. Fumonisins are currently the focus of a FDA long-term tumor study. This review summarizes recent research on (i) the role of sphingolipids as important components of the diet, (ii) the role of sphingoid base metabolites and the ceramide cycle in expression of genes regulating cell growth, differentiation, and apoptosis, (iii) the use of cerebroside synthase inhibitors as tools for understanding the role of sphingolipids as mediators of cell cycle progression, renal disease, and stress responses, and (iv) the involvement of disrupted sphingolipid metabolism in animal disease and cellular deregulation associated with exposure to inhibitors of ceramide synthase and serine palmitoyltransferase, key enzymes in de novo sphingolipid biosynthesis. These findings illustrate how an understanding of the function of sphingolipids can help solve questions in toxicology and this is undoubtedly only the beginning of this story.

Special Section on Therapeutic Implications for Sphingolipids in Health and Disease--Editorial

Perspective: Therapeutic Implications for Sphingolipids in Health and Disease

A review of sphingolipids from marine sources and their analytical method, metabolic process, and essential roles in human health

Regulation of cellular and systemic sphingolipid homeostasis

Sphingosine 1-phosphate: Lipid signaling in pathology and therapy

Mysterious sphingolipids: metabolic interrelationships at the center of pathophysiology

Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy.

Emerging Roles for Sphingolipids in Cardiometabolic Disease: A Rational Therapeutic Target?

Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology

Mechanistic and Therapeutic Implications of Protein and Lipid Sialylation in Human Diseases

Emerging roles of sphingosylphosphorylcholine in modulating cardiovascular functions and diseases

Bioactive sphingolipids: Advancements and contributions from the laboratory of Dr. Lina M. Obeid

Drug Development in the Field of Sphinogolipid Metabolism

Therapeutic Potential for Sphingolipids in Inflammatory Bowel Disease and Colorectal Cancer

Tackling the biophysical properties of sphingolipids to decipher their biological roles

Special Section on Cannabinoid Signaling in Human Health and Disease--Editorial

An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators

Advances in the Chemistry and Biology of Specialised Pro-Resolving Mediators (SPMs)

Potential Therapeutic Targets for Atherosclerosis in Sphingolipid Metabolism

Sphingolipid Analysis in Clinical Research

Sphingolipids and their metabolism in physiology and disease